Safety of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease undergoing concomitant treatment with immunosuppressant medications: A multicentre cohort study

(1) Sapporo Kosei General Hospital,Sapporo,Japan

(2) Juntendo University School of Medicine,Bunkyo,Japan

(3) Juntendo University Urayasu Hospital,Chiba,Japan

(4) JIMRO Co., Ltd.,Tokyo,Japan

This item was part of the IBD I (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019